Brief: Promore Pharma Q3 Operating Loss Narrows To SEK 6.7 Mln
Nov 22 (Reuters) - Promore Pharma AB PROMO.ST :
* Q3 NET SALES SEK 1.3 MILLION VERSUS SEK 1.0 MILLION YEAR
AGO
* Q3 OPERATING LOSS SEK 6.7 MILLION VERSUS LOSS SEK 7.4
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr8mH0KW
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality